Back to results
US 2013/0210920 A1Published application
Desensitizing drug product
AssigneeAbsorption Pharmaceuticals, LLC
InventorsRonald Gilbert, Anthony C. Capomacchia, Jody Helfend
Life of this patent
Estimating the term…
Abstract
Desensitizing drug products, methods of making desensitizing drug products, and methods of using desensitizing drug products including delivery of desensitizing drug products. In one embodiment, the desensitizing drug products are male genital desensitizers that comprise one or anesthetic agents and one or more melting point depressing agents.
Claims14
1-4. (canceled)
A method for treating premature ejaculation in males, comprising the step of administering to a male subject a male genital desensitizer composition, wherein the male genital desensitizer composition comprises:
- an anesthetic agent;
- a first melting point depressing agent selected from the group consisting of thymol, methyl salicylate, phenyl salicylate, butylated hydroxytoluene, butylated hydroxyanisole, S(+)-ibuprofen, R(−)-ibuprofen, cineole, eugenol, capsaicin, eucalyptol, and an alcohol;
- and
- a second melting point depressing agent selected from the group consisting of thymol, methyl salicylate, phenyl salicylate, butylated hydroxytoluene, butylated hydroxyanisole, S(+)-ibuprofen, R(−)-ibuprofen, cineole, eugenol, capsaicin, eucalyptol, and an alcohol, and wherein the second melting point depressing agent is different from the first melting point depressing agent.
1 more element
Dependencies are inferred from the claim text.